Silverberg et al. showed that for 179 patients with mild to moderate chronic kidney disease and moderate to severe heart failure, the administration of iron and EPO for the treatment of anemia was associated with a better left ventricular systolic function and an improvement in renal function [23]. The gene discussed is EPO; the disease is anemia (phenotype).